Cardiovascular Systems’ Stealth 360° PAD System Honored as a New Technology of the Year by LifeScience Alley
December 13 2011 - 8:00AM
Business Wire
Cardiovascular Systems, Inc. (CSI; Nasdaq: CSII), Stealth 360°™
PAD System has been honored as a New Technology of the Year by
LifeScience Alley. The annual award is given to the top 10 novel
products that address a medical need, demonstrate the ability to
improve healthcare and have significant market potential. Expert
industry judges selected ground-breaking medical and health care
technologies from established and emerging organizations from
around the U.S. and Canada. Companies presented their
technologies at New Technology Showcase of the LifeScience Alley
Conference & Expo in Minneapolis, which drew approximately
1,500 professionals from more than 12 countries and 30 states.
“We thank LifeScience Alley for this recognition — a direct
reflection of the hard work and many contributions of our talented
employees in Minnesota,” said David L. Martin, CSI president and
chief executive officer. “This honor recognizes CSI’s innovative
technology to safely treat routine and complex peripheral arterial
disease (PAD) cases. The Stealth 360° removes harmful plaque from
arteries in a very short treatment time in the hospital or
physician’s office. Our technologies, combined with our growing
wealth of clinical data, are helping physicians achieve a new
standard of care for PAD patients to save limbs and lives.”
The Stealth 360° utilizes CSI’s proven orbital mechanism of
action, which protects healthy tissue while removing
difficult-to-treat plaque in patients with peripheral arterial
disease. The Stealth 360° eliminates the large capital equipment
portion of its predecessor product for a more compact and
easier-to-use system. With simple, convenient speed adjustments on
the handle, physicians can vary the speed of orbit and have greater
control to achieve shorter procedure times and a high percentage of
plaque reduction. The device also reduces set-up and staff
time.
About LifeScience Alley
LifeScience Alley is an international leader in sharing best
practices, and is the largest state-based life sciences trade
association in the United States. With a 26-year track record of
providing valuable services and results-oriented outcomes to its
members, LifeScience Alley enables business success through
educating workforces, influencing state and federal public policy,
supporting advancement in research and technological innovation,
and fostering industry connections. The Association’s membership
employs approximately 250,000 Minnesotans and its reach extends
throughout the Midwest and Canada. For additional information,
visit: www.LifeScienceAlley.org.
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a
medical device company focused on developing and commercializing
innovative solutions for treating vascular and coronary disease.
The company's Stealth 360°TM, Diamondback 360® and Predator 360®
PAD Systems treat calcified and fibrotic plaque in arterial vessels
throughout the leg in a few minutes of treatment time, and address
many of the limitations associated with existing surgical, catheter
and pharmacological treatment alternatives. The U.S. FDA granted
510(k) clearance for the use of the Diamondback 360° in August
2007, the Predator 360° in March 2009 and for the Stealth 360° in
March 2011. To date, more than 55,000 PAD procedures have been
performed using CSI's PAD systems in leading institutions across
the United States.
CSI has also commenced its ORBIT II Investigational Device
Exemption clinical trial to evaluate the safety and effectiveness
of its orbital technology in treating coronary arteries. The
coronary system is limited by federal law to investigational use
and is currently not commercially available in the United
States.
For more information, visit the company’s website at
www.csi360.com.
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jul 2023 to Jul 2024